Ken Fisher Cogent Biosciences, Inc. Transaction History
Fisher Asset Management, LLC
- $243 Billion
- Q3 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 129,415 shares of COGT stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,415
Previous 149,045
13.17%
Holding current value
$1.18 Million
Previous $1.26 Million
11.23%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding COGT
# of Institutions
171Shares Held
113MCall Options Held
56.7KPut Options Held
40.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$95.6 Million0.31% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.24MShares$84.4 Million8.19% of portfolio
-
Commodore Capital LP New York, NY7.54MShares$68.8 Million6.92% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$66.5 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$63.6 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $600M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...